Chemical Bank’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-13,750
Closed -$1.1M 380
2016
Q4
$1.1M Sell
13,750
-300
-2% -$23.8K 0.13% 159
2016
Q3
$1.12M Hold
14,050
0.15% 139
2016
Q2
$1.1M Hold
14,050
0.15% 138
2016
Q1
$773K Hold
14,050
0.11% 164
2015
Q4
$868K Hold
14,050
0.12% 160
2015
Q3
$886K Hold
14,050
0.13% 164
2015
Q2
$1.03M Hold
14,050
0.14% 156
2015
Q1
$919K Sell
14,050
-10
-0.1% -$665 0.12% 168
2014
Q4
$914K Hold
14,060
0.12% 170
2014
Q3
$845K Buy
14,060
+10
+0.1% +$653 0.15% 147
2014
Q2
$973K Hold
14,050
0.17% 131
2014
Q1
$919K Hold
14,050
0.17% 139
2013
Q4
$870K Hold
14,050
0.15% 141
2013
Q3
$754K Sell
14,050
-7
-0% -$361 0.15% 148
2013
Q2
$641K Buy
+14,057
New +$609K 0.13% 157

Other funds holding STJ

Chemical Bank's STJ Position: Q1 2017 in Review

Chemical Bank sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 13,750 shares — an estimated $1.1M sold.

Chemical Bank first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $1.12M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Chemical Bank reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Chemical Bank sold 13,750 St Jude Medical shares in Q1 2017, an estimated $1.1M.
  • Chemical Bank first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Chemical Bank's St Jude Medical position peaked at $1.12M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Chemical Bank's 13F filing for Q1 2017, filed 15 May 2017.